Published in Eur Respir J on June 01, 2001
Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax (2004) 1.49
Circulating alpha1-antitrypsin in the general population: determinants and association with lung function. Respir Res (2008) 0.94
Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals. Respir Res (2008) 0.81
Inflammatory markers in chronic obstructive pulmonary disease patients with different α1 antitrypsin genotypes. Arch Med Sci (2012) 0.77
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology (2000) 3.49
Autosomal linkage between the Gm and Pi loci in man. Ann Hum Genet (1972) 3.34
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol (1992) 3.09
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet (1990) 2.73
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J (1999) 2.44
The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera. Clin Chim Acta (1967) 2.14
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol (1999) 2.02
Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey. Thorax (2004) 1.99
Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol (1997) 1.98
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88
Serum Pi types in patients with pulmonary diseases. Acta Allergol (1969) 1.86
Serum prealbumin: polymorphism in man. Science (1965) 1.81
Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax (1991) 1.79
Quantitative studies on the inherited variants of serum alpha-1-antitrypsin. Scand J Clin Lab Invest (1969) 1.79
The Pi system-inherited variants of serum alpha 1-antitrypsin. Prog Med Genet (1970) 1.69
The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin. Adv Hum Genet (1981) 1.67
Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II. Tech Coloproctol (2013) 1.66
Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978. Hum Genet (1980) 1.66
High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut (1999) 1.63
Impact of the World Health Organization's Surgical Safety Checklist on safety culture in the operating theatre: a controlled intervention study. Br J Anaesth (2013) 1.62
CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J (2009) 1.62
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J (2009) 1.62
Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J (2009) 1.61
Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community. Eur Respir J (1993) 1.61
Total and specific serum IgE levels in adults: relationship to sex, age and environmental factors. Clin Exp Allergy (1994) 1.60
Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet (1986) 1.58
Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax (2005) 1.58
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol (1985) 1.53
Prevalence of airway symptoms among hairdressers in Bergen, Norway. Occup Environ Med (2001) 1.52
Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up. COPD (2014) 1.49
Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax (2010) 1.46
Serum Pi types in Norwegians. Acta Pathol Microbiol Scand (1967) 1.44
Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.44
Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trondelag Health Study (HUNT). J Epidemiol Community Health (2000) 1.44
Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study. Thorax (2008) 1.43
How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med (1999) 1.42
A prospective study of reproductive factors and breast cancer. I. Parity. Am J Epidemiol (1987) 1.42
Postal survey on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-response. J Epidemiol Community Health (1990) 1.41
Total serum IgE and FEV1 by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clin Exp Allergy (1995) 1.40
Sex differences in lung vulnerability to tobacco smoking. Eur Respir J (2003) 1.38
Trends in symptoms of obstructive lung disease in Norway. Int J Tuberc Lung Dis (2004) 1.38
Long-term changes in adult asthma prevalence. Eur Respir J (2003) 1.38
Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag Study. Eur Respir J (2001) 1.37
Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem (1983) 1.35
Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J (2004) 1.30
Bronchial responsiveness in a Norwegian community. Am Rev Respir Dis (1991) 1.29
Smoking and immunoglobulin levels. Lancet (1979) 1.29
Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol (1995) 1.28
Postoperative complications and mortality after surgery for gastric cancer. Ann Surg (1988) 1.26
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy (2008) 1.26
Association of asthma and hay fever with irregular menstruation. Thorax (2005) 1.25
Do farming exposures cause or prevent asthma? Results from a study of adult Norwegian farmers. Thorax (2004) 1.24
High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. Eur Respir J (1994) 1.23
Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haematol (1970) 1.22
A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway. Spinal Cord (2009) 1.22
Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma. Scand J Clin Lab Invest (1970) 1.21
Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis (2005) 1.19
A prospective study of asthma incidence and its predictors: the RHINE study. Eur Respir J (2004) 1.19
Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway. Eur Respir J (1998) 1.17
Occupational dust or gas exposure and prevalences of respiratory symptoms and asthma in a general population. Eur Respir J (1991) 1.16
Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med (2006) 1.16
The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol (1988) 1.16
Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol (1993) 1.16
Prevalence of respiratory symptoms in the city of Oslo. Scand J Respir Dis (1979) 1.14
Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial. Br J Surg (1993) 1.14
Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.14
Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs. Eur J Clin Microbiol Infect Dis (2010) 1.13
Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol (1993) 1.13
Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open (2012) 1.13
Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr (2004) 1.12
Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. Eur Respir J (2002) 1.12
Genetics of the Pi serum types. Family studies of the inherited variants of serum alpha-1-antitrypsin. Hum Hered (1969) 1.12
Endorectal elastography in the evaluation of rectal tumours. Colorectal Dis (2011) 1.11
Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum (1998) 1.09
The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol (1995) 1.09
Prevalence and manifestations of obstructive lung disease in the city of Oslo. Scand J Respir Dis (1979) 1.08
Protease inhibitor (Pi) phenotypes in chromosome aberrations. J Med Genet (1970) 1.08
The International Journal of Tuberculosis and Lung Disease--a home for respiratory epidemiology. Int J Tuberc Lung Dis (1998) 1.08
Averaging attributable fractions in the multifactorial situation: assumptions and interpretation. J Clin Epidemiol (1998) 1.07
Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child (1996) 1.07
Is birth weight related to lung function and asthma symptoms in Nordic-Baltic adults? Respir Med (2004) 1.07
Overweight and obesity in Norwegian children: secular trends in weight-for-height and skinfolds. Acta Paediatr (2007) 1.06